Chronic disulfiram treatment effects on intranasal cocaine administration: initial results

Biological Psychiatry
Elinore F McCance-KatzP Jatlow

Abstract

Simultaneous abuse of cocaine and alcohol is common. Alcohol decreases negative stimulant effects and potentiates "high." Disulfiram (Antabuse) is being studied in outpatient trials as a cocaine pharmacotherapy with the rationale that inability to modulate cocaine effects with alcohol may decrease cocaine use. We examined the interaction of disulfiram and cocaine in a randomized, double-blind, placebo-controlled study where subjects were chronically treated with disulfiram and then participated in intranasal cocaine administration studies. Disulfiram 250 mg/day treatment significantly increased plasma cocaine concentrations (p = .013), heart rate (cocaine 1 mg/kg, p = .046), and systolic (cocaine 2 mg/kg p = .003) and diastolic (cocaine 2 mg/kg, p = .022) blood pressure. "High" and "nervous" ratings were nonsignificantly increased. The combination of "high" with increased anxiety in the context of inability to lessen negative effects with alcohol may be an effective treatment in selected patients. The significant pharmacokinetic interaction must be considered in the decision regarding use of disulfiram.

References

Feb 1, 1976·European Journal of Pharmacology·M M Asaad, D E Clarke
Feb 1, 1990·Alcoholism, Clinical and Experimental Research·A Helander, S Carlsson
Feb 1, 1990·Drug and Alcohol Dependence·B F Grant, T C Harford
Dec 1, 1988·The Journal of Nervous and Mental Disease·R D WeissJ L Michael
Jan 1, 1983·Pharmacology, Biochemistry, and Behavior·M W FischmanY Hatano
Jul 1, 1995·The Journal of Pharmacology and Experimental Therapeutics·E F McCanceP I Jatlow
Jan 1, 1993·Pharmacology & Toxicology·N L Benowitz

❮ Previous
Next ❯

Citations

Jan 21, 2006·Der Nervenarzt·G Wiesbeck, K Dürsteler-MacFarland
Sep 16, 2005·Psychopharmacology·Brooke N Bourdélat-ParksDavid Weinshenker
Dec 21, 2000·Current Psychiatry Reports·G O'Leary, R D Weiss
May 30, 2001·Drug and Alcohol Dependence·A OlivetoT R Kosten
Oct 27, 1998·Drug and Alcohol Dependence·E F McCance-KatzP Jatlow
Aug 26, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jason P SchroederDavid Weinshenker
May 17, 2006·Journal of Clinical Psychopharmacology·Jesse J SuhCharles P O'Brien
Apr 28, 2006·Current Opinion in Psychiatry·Frank J Vocci, Ahmed Elkashef
Jan 15, 2009·Journal of Clinical Psychopharmacology·Jochen MutschlerFalk Kiefer
Oct 17, 2009·Clinical Neuropharmacology·Stephen Ross, Eric Peselow
Oct 17, 2009·Clinical Neuropharmacology·Stephen Ross, Eric Peselow
Sep 2, 2009·Molecular Interventions·Meriem Gaval-Cruz, David Weinshenker
Jul 6, 2004·Drugs·David A GorelickZheng-Xiong Xi
Aug 22, 2012·Biological Psychiatry·Thomas R KostenDavid A Nielsen
Mar 11, 2008·Pharmacology, Biochemistry, and Behavior·Meriem Gaval-CruzDavid Weinshenker
May 26, 2004·Pharmacology, Biochemistry, and Behavior·Richard W Foltin, Margaret Haney
Jul 9, 2004·Addictive Behaviors·Charla NichKathleen M Carroll
Oct 24, 2003·Biological Psychiatry·Colin N HaileTherese A Kosten
Apr 10, 2013·Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina·Leonardo BaldaçaraCamila Campitelli Fernandes
Mar 6, 2013·Neuroscience Letters·Thomas R KostenDavid A Nielsen
Jan 28, 2014·Drug and Alcohol Dependence·Richard S SchottenfeldThomas R Kosten
Mar 15, 2015·Behavioural Pharmacology·Nathan A Holtz, Marilyn E Carroll
Jan 21, 2015·Progress in Neuro-psychopharmacology & Biological Psychiatry·Richard De La GarzaKathryn A Cunningham
Jan 4, 2001·Substance Use & Misuse·B K Boyarsky, E F McCance-Katz
May 23, 2009·The American Journal of Drug and Alcohol Abuse·Colin N HaileTherese A Kosten
Aug 3, 2007·Biochemical Pharmacology·Michael D Köhnke
Jan 22, 2010·The Cochrane Database of Systematic Reviews·Pier Paolo PaniMarina Davoli
Dec 14, 2006·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David Weinshenker, Jason P Schroeder
Sep 27, 2013·The Journal of Pharmacology and Experimental Therapeutics·Daniel F ManvichDavid Weinshenker

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.